InsiderTrades.com logo

SNTI Insider Trading

Insider Ownership Percentage: 3.12%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $24,412.87

Senti Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Senti Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Senti Biosciences Share Price & Price History

Current Price: $2.22
Price Change: ▲ Price Increase of +0.02 (0.91%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for SNTI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Senti Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/6/2025Kanya RajangamInsiderSell182$4.37$795.348,621View SEC Filing Icon  
2/6/2025Timothy K LuCEOSell545$4.36$2,376.2082,082View SEC Filing Icon  
2/4/2025Kanya RajangamInsiderSell1,297$4.07$5,278.798,803View SEC Filing Icon  
2/4/2025Timothy K LuCEOSell3,922$4.07$15,962.5482,627View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Senti Biosciences (NASDAQ:SNTI)

25.70% of Senti Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SNTI by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Senti Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Citadel Advisors LLC82,753$0.12M0.0%N/A0.316%Search for SEC Filing on Google Icon
8/14/2025Armistice Capital LLC892,207$1.88M0.0%N/A3.411%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC147,314$0.31M0.0%+395.6%0.565%Search for SEC Filing on Google Icon
5/15/2025Nantahala Capital Management LLC888,000$2.98M0.1%N/A3.405%Search for SEC Filing on Google Icon
5/15/2025Heights Capital Management Inc.750,000$2.52M1.3%N/A2.876%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC51,600$0.18M0.0%N/A1.071%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC13,356$47K0.0%N/A0.277%Search for SEC Filing on Google Icon
11/14/2024NEA Management Company LLC442,615$1M0.1%-90.0%9.664%Search for SEC Filing on Google Icon
11/7/20248VC GP I LLC253,755$0.57M0.8%-90.0%5.541%Search for SEC Filing on Google Icon
10/31/2024ARK Investment Management LLC176,666$0.40M0.0%-88.9%3.858%Search for SEC Filing on Google Icon
7/26/2024ARK Investment Management LLC1,585,772$0.44M0.0%-2.8%34.624%Search for SEC Filing on Google Icon
2/12/20248VC GP I LLC2,537,558$1.68M1.7%N/A5.697%Search for SEC Filing on Google Icon
1/17/2024ARK Investment Management LLC1,969,860$1.30M0.0%+7.9%4.423%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc241,208$0.10M0.0%+88.4%0.542%Search for SEC Filing on Google Icon
9/7/2023Triatomic Management LP300,533$0.19M0.2%+42.5%0.675%Search for SEC Filing on Google Icon
7/10/2023ARK Investment Management LLC1,829,815$1.15M0.0%-3.8%4.143%Search for SEC Filing on Google Icon
5/3/2023Triatomic Management LP210,883$0.25M0.2%+39.0%0.477%Search for SEC Filing on Google Icon
4/17/2023ARK Investment Management LLC1,901,467$2.24M0.0%-1.3%4.305%Search for SEC Filing on Google Icon
2/14/2023Triatomic Management LP151,675$0.21M0.2%+168.7%0.346%Search for SEC Filing on Google Icon
2/13/2023Artal Group S.A.55,555$78K0.0%-94.7%0.127%Search for SEC Filing on Google Icon
2/7/2023TD Asset Management Inc118,292$0.17M0.0%-12.3%0.270%Search for SEC Filing on Google Icon
1/24/2023ARK Investment Management LLC1,925,827$2.72M0.0%-7.8%4.391%Search for SEC Filing on Google Icon
11/15/2022Triatomic Management LP56,454$0.12M0.1%N/A0.129%Search for SEC Filing on Google Icon
11/7/2022TD Asset Management Inc.134,892$0.29M0.0%+53.8%0.308%Search for SEC Filing on Google Icon
11/3/2022The Manufacturers Life Insurance Company117,707$0.25M0.0%N/A0.269%Search for SEC Filing on Google Icon
10/17/2022ARK Investment Management LLC2,087,696$4.53M0.0%N/A4.771%Search for SEC Filing on Google Icon
8/11/2022Artal Group S.A.1,055,555$2.07M0.1%N/A4.450%Search for SEC Filing on Google Icon
8/8/2022Allen Operations LLC21,443$42K0.0%N/A0.090%Search for SEC Filing on Google Icon
8/4/2022TD Asset Management Inc.87,696$0.17M0.0%N/A0.370%Search for SEC Filing on Google Icon
7/29/2022Kingfisher Capital LLC113,163$0.22M0.1%N/A0.477%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Senti Biosciences logo
Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Read More on Senti Biosciences

Today's Range

Now: $2.22
Low: $2.10
High: $2.23

50 Day Range

MA: $1.91
Low: $1.39
High: $2.31

52 Week Range

Now: $2.22
Low: $1.26
High: $7.10

Volume

111,823 shs

Average Volume

95,153 shs

Market Capitalization

$58.36 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.08

Who are the company insiders with the largest holdings of Senti Biosciences?

Senti Biosciences' top insider investors include:
  1. Timothy K Lu (CEO)
  2. Kanya Rajangam (Insider)
Learn More about top insider investors at Senti Biosciences.

Who are the major institutional investors of Senti Biosciences?

Senti Biosciences' top institutional investors include:
  1. Citadel Advisors LLC — 0.32%
Learn More about top institutional investors of Senti Biosciences stock.

Which institutional investors are buying Senti Biosciences stock?

During the last quarter, SNTI stock was purchased by institutional investors including:
  1. Citadel Advisors LLC